Merck withdraws cholesterol drug Tredaptive globally
Jan 11 (Reuters) - Merck & Co Inc said it would withdraw its cholesterol drug Tredaptive from markets worldwide after European regulators recommended that marketing of the drug be suspended.
The drug was under review in Europe after the failure of a major study raised safety concerns.
Merck recommended that physicians stop prescribing the drug and review treatment plans for patients taking it.
- Children's corpses in Korean ferry reveal desperate attempts to escape |
- Obama reassures Japan, other allies on China ahead of visit |
- Ukraine government resumes offensive, hopes for more U.S. help |
- Ukraine president calls for new anti-rebel offensive as crisis deal falters |
- Search for MH370 reveals a military vulnerability for China